Skip Navigation LinksHome > March/April 2012 - Volume 1 - Issue 2 > An Update in Laser and Pharmaceutical Treatment for Polypoid...
Asia-Pacific Journal of Ophthalmology:
doi: 10.1097/APO.0b013e31823e5a95
Review Article

An Update in Laser and Pharmaceutical Treatment for Polypoidal Choroidal Vasculopathy

Lai, Timothy Y.Y. MD, FRCS, FRCOphth,*†; Chan, Wai-Man FRCP, FRCOphth*‡

Collapse Box


Abstract: Polypoidal choroidal vasculopathy (PCV) is a condition characterized by multiple, recurrent, serosanguineous pigment epithelium detachment and neurosensory retinal detachment due to abnormal choroidal polypoidal lesions. Polypoidal choroidal vasculopathy is particularly prevalent in Asians and occurs in up to 30% of patients presenting with neovascular age-related macular degeneration. In recent years, various treatment modalities have been described in the literature for the treatment of PCV. This review article aims to provide an overview and to summarize the current nonsurgical treatment for PCV.

© 2012Asia-Pacific Academy of Ophthalmology

You currently do not have access to this article.

You may need to:

Note: If your society membership provides for full-access to this article, you may need to login on your society’s web site first.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.